Twelve-Hour Glycemic Profiles With Meals of High, Medium, or Low Glycemic Load
Open Access
- 1 December 2005
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (12) , 2981-2983
Abstract
Tion, and worsened glycemic control, which might be related to the cytochrome P450-mediated metabolic pathway (4,5). The results in this study are an important observation for patients with diabetes and are consistent with another report that pitavastatin, which is metabolized with little involvement of cytochrome P450 isoenzymes (4), did not show these major adverse effects (6). Because pitavastatin has been marketed for only a few years, further studies with a greater number of subjects and a longer duration are needed to establish the safety of this agent. In conclusion, pitavastatin is effective in lowering LDL cholesterol and triglyceride levels without affecting glycemic control in patients with diabetes. We believe that this agent must also help prevent the development of macrovascular disease in diabetic patients,Keywords
This publication has 5 references indexed in Scilit:
- Continuous Glucose MonitoringDiabetes Care, 2005
- Acute Onset and Worsening of Diabetes Concurrent with Administration of StatinsEndocrine Journal, 2005
- Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting GlucoseDiabetes Care, 2003
- Physiological Validation of the Concept of Glycemic Load in Lean Young AdultsThe Journal of Nutrition, 2003
- The Glycemic IndexJAMA, 2002